Nhu cầu đào tạo chéo giữa các nhân viên y tế cộng đồng trong lĩnh vực HIV và sử dụng chất gây nghiện

BMC Medical Education - Tập 22 - Trang 1-9 - 2022
Kasey Claborn1, Kelli Scott2,3, Sara J. Becker2,3
1Department of Psychiatry, University of Texas at Austin Dell Medical School, Austin, USA
2Center for Alcohol and Addiction Studies, Brown University School of Public Health, Providence, USA
3Northwestern University Feinberg School of Medicine, Chicago, USA

Tóm tắt

Những người mắc cùng lúc HIV và sử dụng chất gây nghiện thường có sự tham gia vào điều trị kém hơn và kết quả điều trị tồi tệ hơn. Đào tạo chéo cho các nhân viên y tế chuyên về HIV và rối loạn sử dụng chất có thể nâng cao quy mô và chất lượng của dịch vụ chăm sóc tích hợp. Nghiên cứu là cần thiết về các lĩnh vực cần đào tạo nhiều nhất của nhân viên y tế để phục vụ việc phát triển chương trình đào tạo. Dữ liệu từ các cuộc phỏng vấn bán cấu trúc với 16 nhân viên y tế về HIV và 13 nhân viên y tế về rối loạn sử dụng chất (N = 29) đã được phân tích bằng cách sử dụng phân tích chủ đề, xoay quanh cả những chủ đề đã đề ra và những chủ đề nổi bật. Nhiều chủ đề quan trọng đã nổi lên qua các chủ đề đã đề ra: 1) kinh nghiệm đào tạo trong quá khứ; 2) khoảng trống trong đào tạo; và 3) định dạng/cấu trúc đào tạo và giám sát. Cả các nhân viên y tế về HIV và sử dụng chất đều báo cáo rằng họ đã nhận được ít đào tạo chéo chính thức và chủ yếu được đào tạo

Từ khóa

#HIV #rối loạn sử dụng chất #đào tạo chéo #nhân viên y tế cộng đồng #điều trị tích hợp

Tài liệu tham khảo

CDC. HIV Surveillance Report: Diagnoses of HIV Infection in the United States and Dependent Areas 2019;32. https://www.cdc.gov/hiv/library/reports/hiv-surveillance/vol-32/index.html Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality. Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings 2011. Gonzalez A, Barinas J, O’Cleirigh C. Substance use: impact on adherence and HIV medical treatment. Curr HIV/AIDS Rep. 2011;8:223–34. https://doi.org/10.1007/s11904-011-0093-5. Das S, Muhetaer K, Alvarado HA. Changes in integrated HIV care in substance use treatment facilities (2015–2020) (the CBHSQ spotlight). Rockville; 2022. https://www.samhsa.gov/data/report/changes-integrated-hiv-su-facilities Weber E, Morgan EE, Iudicello JE, Blackstone K, Grant I, Ellis RJ, et al. Substance use is a risk factor for neurocognitive deficits and neuropsychiatric distress in acute and early HIV infection. J Neuro-Oncol. 2013;19:65–74. https://doi.org/10.1007/s13365-012-0141-y. Wang C, Vlahov D, Galai N, Cole SR, Bareta J, Pollini R, et al. The effect of HIV infection on overdose mortality. AIDS. 2005;19:935–42. https://doi.org/10.1097/01.aids.0000171407.30866.22. Altice FL, Kamarulzaman A, Soriano VV, Schechter M, Friedland GH. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet. 2010;376:367–87. https://doi.org/10.1016/S0140-6736(10)60829-X. Chen IM, Huang CLC, Yeh BJ, Chien YL. Health service utilization of heroin abusers: a retrospective cohort study. Addict Behav. 2015;45:281–6. https://doi.org/10.1016/j.addbeh.2015.01.042. Onyeka IN, Beynon CM, Ronkainen K, Tiihonen J, Föhr J, Kuikanmäki O, et al. Hospitalization in a cohort seeking treatment for illicit drug use in Finland. J Subst Abus Treat. 2015;53:64–70. https://doi.org/10.1016/j.jsat.2014.12.009. Andersen R, Bozzette S, Shapiro M, St Clair P, Morton S, Crystal S, et al. Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. HCSUS consortium. HIV cost and services utilization study. Health Serv Res. 2000;35:389–416. Cunningham CO, Sohler NL, Cooperman NA, Berg KM, Litwin AH, Arnsten JH. Strategies to improve access to and utilization of health care services and adherence to antiretroviral therapy among HIV-infected drug users. Subst Use Misuse. 2011;46:218–32. https://doi.org/10.3109/10826084.2011.522840. Conway FN, Rountree MA, Jones KV. Serving the co-morbid mental health and substance use needs of people with HIV. Community Ment Health J. 2021;57:1328–39. https://doi.org/10.1007/S10597-020-00756-8/TABLES/2. Biancarelli DL, Biello KB, Childs E, Drainoni M, Salhaney P, Edeza A, et al. Strategies used by people who inject drugs to avoid stigma in healthcare settings. Drug Alcohol Depend. 2019;198:80–6. https://doi.org/10.1016/j.drugalcdep.2019.01.037. Giordano TP, Hartman C, Gifford AL, Backus LI, Morgan RO. Predictors of retention in HIV care among a national cohort of US veterans. HIV Clin Trials. 2009;10:299–305. https://doi.org/10.1310/hct1005-299. The White House. National HIV/AIDS strategy for the United States 2022–2025. Washington, D.C.; 2021. https://www.whitehouse.gov/wp-content/uploads/2021/11/National-HIV-AIDS-Strategy.pdf. National Academies of Sciences, Engineering, and Medicine. Opportunities to improve opioid use disorder and infectious disease services: Integrating responses to a dual epidemic. Washington, DC: The National Academies Press; 2020. https://doi.org/10.17226/25626. Springer SA, Barocas JA, Wurcel A, Nijhawan A, Thakarar K, Lynfield R, et al. Federal and state action needed to end the infectious complications of illicit drug use in the United States: IDSA and HIVMA’s advocacy agenda. J Infect Dis. 2020;222:S230–8. https://doi.org/10.1093/infdis/jiz673. Lazo M, Gange SJ, Wilson TE, Anastos K, Ostrow DG, Witt MD, et al. Patterns and predictors of changes in adherence to highly active antiretroviral therapy: longitudinal study of men and women. Clin Infect Dis. 2007;45:1377–85. https://doi.org/10.1086/522762. Wohl AR, Carlos JA, Tejero J, Dierst-Davies R, Daar ES, Khanlou H, et al. Barriers and unmet need for supportive services for HIV patients in care in Los Angeles County, California. AIDS Patient Care STDs. 2011;25:525–32. https://doi.org/10.1089/apc.2011.0149. Montague BT, Kahler CW, Colby SM, McHugh RK, Squires D, Fitzgerald B, et al. Attitudes and training needs of new England HIV care and addiction treatment providers: opportunities for better integration of HIV and alcohol treatment services. Addict Disord Their Treat. 2015;14:16–28. https://doi.org/10.1097/ADT.0000000000000040. Claborn K, Becker S, Operario D, Safren S, Rich JD, Ramsey S. Adherence intervention for HIV-infected persons who use drugs: adaptation, open trial, and pilot randomized hybrid type 1 trial protocol. Addict Sci Clin Pract. 2018;13:1–11. https://doi.org/10.1186/s13722-018-0113-5. Singer M, Clair S. Syndemics and public health: Reconceptualizing disease in bio-social context. Med Anthropol Q. 2003;17:423–41. https://doi.org/10.1525/MAQ.2003.17.4.423. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups | The EQUATOR Network. https://www.equator-network.org/reporting-guidelines/coreq/. Accessed 6 June 2022. Guest G, Macqueen KM, Namey EE. Introduction to Applied Thematic Analysis In: Applied Thematic Analysis Introduction to Applied Thematic Analysis 2014. https://doi.org/10.4135/9781483384436. Polydorou S, Gunderson EW, Levin FR. Training Physicians to Treat Substance Use Disorders. 2008. Gray S. UMMS developing training program on medication-assisted opioid addiction treatment. UMass MedNow. 2018. https://www.umassmed.edu/news/news-archives/2018/11/umms-developing-training-program-on-medication-assisted-opioid-addiction-treatment. Accessed 9 Aug 2022. Zerbo E, Traba C, Matthew P, Chen S, Holland BK, Levounis P, et al. DATA 2000 waiver training for medical students: lessons learned from a medical school experience. Subst Abus. 2020;41:463–7. https://doi.org/10.1080/08897077.2019.1692323. Scott K, Murphy CM, Yap K, Moul S, Hurley L, Becker SJ. Health professional stigma as a barrier to contingency management implementation in opioid treatment programs. Transl Issues Psychol Sci. 2020. https://doi.org/10.1037/tps0000245. Browne T, Priester MA, Clone S, Iachini A, DeHart D, Hock R. Barriers and facilitators to substance use treatment in the rural south: a qualitative study. J Rural Health. 2016;32:92–101. https://doi.org/10.1111/jrh.12129. Lunze K, Lioznov D, Cheng DM, Nikitin RV, Coleman SM, Bridden C, et al. HIV stigma and unhealthy alcohol use among people living with HIV in Russia. AIDS Behav. 2017;21:2609–17. https://doi.org/10.1007/s10461-017-1820-8. Claborn K, Becker S, Ramsey S, Rich J, Friedmann PD. Mobile technology intervention to improve care coordination between HIV and substance use treatment providers: development, training, and evaluation protocol. Addict Sci Clin Pract. 2017;12:1–12. https://doi.org/10.1186/s13722-017-0073-1. Nyblade L, Stockton MA, Giger K, Bond V, Ekstrand ML, Lean RM, et al. Stigma in health facilities: why it matters and how we can change it. BMC Med. 2019;17:25. https://doi.org/10.1186/s12916-019-1256-2. Turan JM, Elafros MA, Logie CH, Banik S, Turan B, Crockett KB, et al. Challenges and opportunities in examining and addressing intersectional stigma and health. BMC Med. 2019;17:1–15. https://doi.org/10.1186/s12916-018-1246-9. Frank HE, Becker-Haimes EM, Kendall PC. Therapist training in evidence-based interventions for mental health: a systematic review of training approaches and outcomes. Clin Psychol Sci Pract. 2020;27:e12330. https://doi.org/10.1111/cpsp.12330. Beidas RS, Cross W, Dorsey S. Show me, don’t tell me: behavioral rehearsal as a training and analogue fidelity tool. Cogn Behav Pract. 2014;21:1–11. Bearman SK, Schneiderman RL, Zoloth E. Building an evidence base for effective supervision practices: an analogue experiment of supervision to increase EBT Fidelity. Adm Policy Ment Health Ment Health Serv Res. 2017;44:293–307. https://doi.org/10.1007/s10488-016-0723-8. Powell BJ, Waltz TJ, Chinman MJ, Damschroder LJ, Smith JL, Matthieu MM, et al. A refined compilation of implementation strategies: results from the expert recommendations for implementing change (ERIC) project. Implement Sci. 2015;10:21. https://doi.org/10.1186/s13012-015-0209-1. Avorn J. Academic detailing “marketing” the best evidence to clinicians. JAMA. 2017;317:361–2. https://doi.org/10.1001/jama.2016.16036.